Targeted cancer drugs are designed to specifically attack cancer cells while minimizing damage to healthy cells, thereby reducing side effects compared to traditional chemotherapy. They work by interfering with specific molecules and pathways that promote tumor growth, division, and spread. This targeted approach is made possible through the identification of specific genetic mutations, biomarkers, or molecular characteristics unique to cancer cells. By exploiting these unique features, targeted cancer drugs offer the potential for improved treatment efficacy and patient outcomes. https://www.innovationmarketresearch.com/market-reports/targeted-cancer-drugs-market/request-sample